BioWin Day 2012 > The programme

9:00       Registration

9:30
       Opening Session

               France Fannes, Managing Director, BioWin.

               Prof. Jean-Luc Balligand, Vice-President, BioWin – Chairman.
           
9:45       Session on technological Innovations

               From stem cells to neurons: opportunities for the modelling and treatment of brain
               diseases
               Prof. Pierre Vanderhaeghen, IRIBHM-ULB.

               Towards therapeutic anticancer vaccines
               Prof. Pierre G.Coulie, De Duve Institute / UCLouvain.

               Next generation DNA sequencing in medical diagnostic: present and future
               Prof. Vincent Bours, CHU de Liège-ULg.

11:15     Coffee Break - Poster session - exhibition

11:45     Innovation beyond Science & Technologies

               Innovation in the perspective of the European Regulatory Authorities
               Dr. Patrick Celis, Committee for Advanced Therapies (CAT)-European Medicines Agency (EMA).

               Bring out innovation in a company: how to mobilize the right capabilities?
               Prof. Benoît Gailly, Louvain School of Management / UCLouvain.

               Innovation for the patients
               Anastassia Negrouk, EORTC and EUPATI.
    
13:15     Lunch and Poster Session
   

14:30     Thematic Workshops

               Innovation in the field of In-Vitro Diagnotics: bridging clinicians and companies
               Thierry Leclipteux, Coris BioConcept and Prof. Vincent Bours, CHU de Liège-ULg.

               How are we going to pay for innovation?
               Damien Bertrand, IBA.

16:30     Coffee Break - Poster session - exhibition

17:00     Closing Session

 
               Poster Awards

               France Fannes, Managing Director, BioWin.

               Jean Stéphenne, President, BioWin – Chairman.

               Innovation for the economy, Innovation for the patients
(presentations)

               Prof. Bruno Delvaux, Chancellor, UCLouvain.               

               Jean-Claude Marcourt, Vice-President and Minister for the Economy, SMEs, Foreign Trade and
               New Technologies of the Walloon Government and Vice-President and Minister for Higher
               Education of the French Community.

               Vincent Brichard, Senior Vice-President and Head of Immunotherapeutics Business Units, GSK
               Vaccines.

               Dr. Panos Kanavos, Reader in International Health Policy, London School of Economics.
  
18:00     Debate animated by Annick Capelle - RTBF

               Keynote speakers

               Jean Stéphenne, BioWin, President – Chairman.

               Prof. Bruno Delvaux, Chancellor, UCLouvain.

               Jean-Claude Marcourt, Vice-President and Minister for the Economy, SMEs, Foreign Trade and
               New Technologies of the Walloon Government and Vice-President and Minister for Higher
               Education of the French Community.

               Vincent Brichard, Senior Vice-President and Head of Immunotherapeutics Business Units, GSK
               Vaccines.

               Dr. Panos Kanavos, Reader in International Health Policy, London School of Economics.

               Special guests

               Prof. Jean-Michel Foidart, Director of LBTD Research Unit, GIGA.

               Michel Goldman, Executive Director, Innovative Medicines Initiative.

               Patricia Garcia-Prieto Chevalier, Representative, Melanoma-ICAB.

               
19:00     Networking Walking Dinner.